Peter B Jones
About
Peter qualified in medicine at Westminster Medical School. Having first worked as a physician at The Whittington Hospital and KCH, he trained in psychiatry at the Maudsley Hospital and epidemiology at the London School of Hygiene. He has been Professor of Psychiatry at Cambridge since 2000, Head of Department of Psychiatry from 2000-2014, and Deputy Head of the Clinical School since 2014. He has been a NIHR CLARHC Director since 2008 and is a NIHR Senior Investigator.
Peter’s research interests are in the epidemiology of mental illness, particularly early life determinants, and in evaluation of effective interventions at the individual and system level. Clinically he co-led the award winning CAMEO.nhs.uk early intervention service until taking on his NIHR responsibilities in the Collaboration for Leadership in Applied Health Research & Care East of England.
Peter studied medicine at KCL and Westminster Medical School. He practised hospital medicine for three years before tasting psychiatry at the Maudsley Hospital and Institute of Psychiatry where he remained for nine years becoming an honorary consultant and senior lecturer; three of these were spent as an MRC Training Fellow and reading Epidemiology at the London School of Hygiene and Tropical Medicine. He was seconded half-time to the Department of Health 1993-1996 where he led the Policy Research Programme Mental Health Research Initiative and convened the multi-party group that led to the reduction in paracetamol pack size as part of the national suicide prevention policy.
After five years at the University of Nottingham, four as Professor of Psychiatry and Community Mental Health, Peter moved to Cambridge in 2000 as Head of Department of Psychiatry and honorary consultant psychiatrist with the Cambridgeshire & Peterborough NHS Foundation Trust.; he was co-founder of the award-winning Cameo early intervention team for young people who experience a first episode of psychosis. In 2014 he stepped-down as Head of Department to become Deputy Head of the School of Clinical Medicine.
Peter was elected a Fellow of Wolfson College in 2003. He is a Director of Cambridge University Health Partners, and Director of the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care for the East of England (CLAHRC EoE). He is a trustee of MQ: transforming mental health, a research charity endowed by the Wellcome Trust, and is an NIHR Senior Investigator Emeritus. Peter has been President of IEPA Early Intervention in Mental Health 2016-2018.
Skills & Expertise
Epidemiology
Research
Neuroimaging
Neuroscience
Research Interests
Public Health
Psychology
Epidemiology
Community mental health
Clinical Medicine
Psychiatry
Clinical Trials
Mental Health Epidemiology
Early Life Determinants of Mental Illness
Early Intervention in Psychosis
Mental Health Policy
Suicide Prevention
Applied Health Research
Intervention Evaluation
Health Services Research
NIHR Leadership
Academic Psychiatry
Psychosis Management
Public Health Interventions
Mental Health Charity
Early Intervention Services
Psychiatry Education
Health Research Collaboration
Connect With Me
Experience
Professor Emeritus & Clinical Director of Research
Director, NIHR ARC East of England (previously CLAHRC) 2008-2022
Deputy Head, School of Clinical Medicine, 2014-2021
Head of Department of Psychiatry, 2000-2014
NED, Cambridgeshire & Peterborough Mental Health Partnership Trust (predecessor organisation to CPFT), 2001-05 and 2017-21
Honorary consultant psychiatrist
Governing Body Fellow
Council member (trustee), 2020-26
Professor of psychiatry & community mental health
Senior Lecturer & honorary consultant psychiatrist
Education
Institute of Psychiatry, Psychology & Neuroscience (IoPPN)
London School of Hygiene & Tropical Medicine (LSHTM)
Westminster Hospital Medical School (WHMS)
King's College London
Projects
Access to Expertise for Cambridge Adaptive Testing - Mental health screening platforms – medical device considerations
Administered by Cambridge Academy of Therapeutic Sciences
Cogs AI - Social - Emotional Screener for Neurodiverse Children
Academic partner (and applicant) with Jan Stochl applying adaptive testing technology to a screening app. Cogs AI is the academic partner.
Early Psychosis Multi-arm Multi-stage Platform Trial (PUMA)
Establishing an adaptive trials platform for early psychosis. CI Belinda Lennox, University of Oxford.
Market research for Cambridge Adaptive Testing Ltd.
Conferences & Seminars (1)
Predicting Population-level Need for Early Treatment Programmes in First Episode Psychosis: The Advanced Psychiatric MAPping Translated into Innovations for Care [PsyMaptic-A] Study
No descriptions
Professional Memberships (2)
University of Cambridge
Country: United Kingdom
Mental Health Research UK
Country: United Kingdom
Patents (3)
Model directed sampling system
description
Matched mailer form
description
Systems and Methods for Managing Documents and Other Electronic Content
description
Publications (221)
Background
First episode psychosis (FEP) patients who use cannabis experience more frequent psychotic and euphoric intoxication experiences compared to controls. It is not clear whether this is conse...
Background
There is consensus that health services commissioning and clinical practice should be driven by scientific evidence. However, workload pressures, accessibility of peer reviewed publication...
Background
Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resista...
Background
Peripheral low-grade inflammation in depression is increasingly seen as a therapeutic target. We aimed to establish the prevalence of low-grade inflammation in depression, using different...
Psychiatry's most recent foray into the area of risk and prevention has been spear-headed by work on at-risk mental states for psychotic disorders. Twenty-five years' research and clinical application...
dd